US SB3788

Requires finished drug products to include labeling identifying the original manufacturer of each active pharmaceutical ingredient (API), the finished drug manufacturer, and any packer or distributor, along with their place of business and unique facility identifier

Allows supply chain information to be provided via package label, link, barcode, QR code, or searchable electronic portal, with paper copies available upon request

Mandates that active pharmaceutical ingredients include manufacturer identification on accompanying labels and certificates of analysis

Defines "original manufacturer" as the last establishment to conduct substantial manufacturing activities before the drug enters interstate commerce

Exempts finished drug products from customs country-of-origin marking requirements if they comply with the new FDA labeling standards; regulations take effect no earlier than 1 year after publication